false
zh-CN,zh-TW,en,fr,de,ja,ko,pt,es,th,vi
Catalog
2023 ACMG Annual Clinical Genetics Meeting Digital ...
Episodic irritability in an ultra-rare genetic dis ...
Episodic irritability in an ultra-rare genetic disorder associated with
NACC1
: imperative to increase awareness and formulate better therapeutic interventions
Back to course
Pdf Summary
This document discusses a study on individuals with a neurodevelopmental disorder caused by a genetic variant in NACC1. These individuals experience episodes of extreme irritability, which can be incapacitating and require medical intervention. The episodes have a significant impact on the affected child and their family. The study analyzed parent narratives to understand the triggers, behavioral changes, and treatments of these episodes. Psychotropic medications were reported to be the most effective in managing the symptoms during the peak phase of the episodes. The study also found that all individuals had scores indicating pain behaviors, suggesting possible paroxysmal sympathetic hyperactivity. The episodes were described as having prodromal, peak, and resolving phases, with vocalizations, abnormal movements, and signs of agitation increasing during the peak phase. The episodes typically end with sleep and tiredness. The frequency and duration of the episodes varied among individuals. While some parents noted improvement over time, no consistent triggers were identified. Various medications were used to manage different symptoms during the episodes, including painkillers, psychotropic medications, gastrointestinal medications, and anti-adrenergic medications. The episodes have a significant emotional impact on families. Support from the medical community is crucial for these families.
Asset Subtitle
Presenting Author - Kelly Schoch, MS, CGC; Co-Author - Allyn McConkie-Rosell, PhD; Co-Author - Nicole Walley, MS; Co-Author - Vikas Bhambhani, MD; Co-Author - Timothy Feyma, MD; Co-Author - Edward C. Smith, MD; Co-Author - Khoon Ghee Queenie Tan, MD, PhD, FACMG; Co-Author - Vandana Shashi, MD;
Meta Tag
Delineation of Diseases
Genotype-Phenotype Correlations
Natural History
Phenotypic delineation of disorders
Co-Author
Allyn McConkie-Rosell, PhD
Co-Author
Nicole Walley, MS
Co-Author
Vikas Bhambhani, MD
Co-Author
Timothy Feyma, MD
Co-Author
Edward C. Smith, MD
Co-Author
Khoon Ghee Queenie Tan, MD, PhD, FACMG
Co-Author
Vandana Shashi, MD
Presenting Author
Kelly Schoch, MS, CGC
Keywords
neurodevelopmental disorder
genetic variant
NACC1
extreme irritability
medical intervention
parent narratives
triggers
behavioral changes
treatments
psychotropic medications
© 2025 American College of Medical Genetics and Genomics. All rights reserved.
×